Could a simple surgery save bones after kidney transplant?

NCT ID NCT07415421

First seen Feb 19, 2026 · Last updated Jun 19, 2026 · Updated 14 times

Summary

This study compares surgery to remove most of the parathyroid glands with standard monitoring in kidney transplant patients who still have high calcium levels. Researchers want to see if surgery improves bone density, physical function, and quality of life over 12 months. The trial will enroll 85 adults who are at least 6 months past their kidney transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERPARATHYROIDISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Departement of Nephrology, Aarhus University hospital

    RECRUITING

    Aarhus, Central Jutland, 8200, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Subtotal parathyroidectomy (surgical removal of most parathyroid glands)

What this could lead to

If surgery proves better than monitoring, it could become a standard option to improve bone health and daily well-being in kidney transplant recipients.

What could go wrong

This is a small pilot study with only 85 participants, so results may not apply to everyone. Surgery carries risks like infection or low calcium levels, and the benefit over monitoring is not yet proven.

Conditions

The condition(s) this trial relates to.

hyperparathyroidism tertiary hyperparathyroidism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.